HCW BIOLOGICS INC (HCWB) Stock Analyst Earnings Estimates
NASDAQ:HCWB - Nasdaq - US40423R2040 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.72M | 2.842M -57.71% | 2.567M -9.68% | 7.145M 178.36% | -100.00% | 163.72M | 378.05M 130.91% | 642.3M 69.90% | ||
| EBITDA YoY % growth | -14.36M -11.93% | -24.86M -73.12% | -27.29M -9.77% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.08M -12.79% | -26M -72.41% | -28.47M -9.50% | -28.935M -1.63% | -37.616M -30.00% | -47.554M -26.42% | 66.189M 239.19% | 236.23M 256.90% | 441.01M 86.69% | |
| Operating Margin | -224.40% | -914.91% | -1,109.16% | -404.97% | N/A | N/A | 40.43% | 62.49% | 68.66% | |
| EPS YoY % growth | -16.80 46.17% | -28.00 -66.67% | N/A 16.94% | -4.69 79.82% | -5.11 -8.91% | -2.77 45.71% | N/A | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 1.84 | -2.35 | -2.48 22.54% | -2.65 |
| Revenue Q2Q % growth | 7.14M 1,053.66% | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 3.284M 121.89% | -4.211M -14.11% | -4.442M -68.90% | -4.758M -179.90% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -3.20 73.33% | 3.67 | -6.87 | -187.15% |
| Q4 2023 Q2Q % growth | -12.00 -100.00% | -5.71 | -6.29 | -110.08% |
| Q3 2023 Q2Q % growth | -5.60 -27.27% | -5.30 | -0.30 | -5.58% |
| Q2 2023 Q2Q % growth | -4.80 -20.00% | -5.98 | 1.18 | 19.79% |
| Q1 2023 Q2Q % growth | -5.60 -133.33% | -5.71 | 0.11 | 1.96% |
| Q4 2022 Q2Q % growth | -6.00 11.24% | -6.73 | 0.73 | 10.87% |
| Q3 2022 Q2Q % growth | -4.40 | -4.90 | 0.50 | 10.13% |
| Q2 2022 Q2Q % growth | -4.00 | -5.10 | 1.10 | 21.57% |
| Q1 2022 Q2Q % growth | -2.40 | -4.49 | 2.09 | 46.52% |
| Q4 2021 Q2Q % growth | -6.76 | -4.90 | -1.86 | -38.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 10K -99.11% | % | ||
| Q4 2024 Q2Q % growth | 395K -70.17% | 7.14M | -6.745M | -94.47% |
| Q3 2024 Q2Q % growth | 426.4K -50.01% | % | ||
| Q2 2024 Q2Q % growth | 618.9K -0.50% | % | ||
| Q1 2024 Q2Q % growth | 1.127M 2,590.31% | % | ||
| Q4 2023 Q2Q % growth | 1.324M -1.19% | 918K | 406K | 44.23% |
| Q3 2023 Q2Q % growth | 853K -52.87% | 306K | 547K | 178.76% |
| Q2 2023 Q2Q % growth | 622K 38.22% | 622K | % | |
| Q1 2023 Q2Q % growth | 41.88K -98.66% | 1.173M | -1.131M | -96.43% |
| Q4 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 79.09% | 79.09% |
| Revenue | N/A | N/A | N/A | N/A |